SurgOnc Today®

In this episode of SurgOnc Today, breast surgical oncologists explore circulating tumor DNA (ctDNA) in early-stage breast cancer and what breast surgeons need to know about this rapidly evolving biomarker. The panel explains what ctDNA is, how it is detected, and its emerging role in identifying molecular residual disease and assessing treatment response. They review the current evidence for ctDNA testing during neoadjuvant therapy, after surgery, and during surveillance, while highlighting important limitations in using ctDNA to guide treatment and surgical decision-making. The conversation also addresses how to counsel patients who request testing and what evidence is still needed before ctDNA can become part of routine breast cancer care.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene and Drs. Samuel Aguiar Jr. & Rebeca Hara Nahime discuss the article: "Robotic Intracorporeal Single-Stapled Anastomosis (RISS) is Associated with Lower Anastomotic Leakage Rates than the Double-Stapled Technique" from the March 2026 Issue of the Annals of Surgical Oncology.

A successful research program requires more than good science—it requires building and leading a strong team. Yet many surgeon-scientists receive little formal training in hiring, managing, and, when necessary, making difficult personnel decisions. In this episode of SurgOnc Today, Drs. Lauren Krumeich, Neal Bhutiani, Stefani Galban, Donnele Daley & Jun Yan discuss practical strategies for recruiting outstanding research staff, identifying the qualities that predict long-term success, fostering a positive and productive team culture, and navigating performance challenges with professionalism and empathy. Through lessons learned from their own experiences, the panel offers actionable advice for junior and established investigators alike on developing and sustaining a high-performing research team.

On this episode of SurgOnc Today, we discuss the complexities of inguinal canal sarcomas, including common presentations and key diagnostics, considerations for resection, reconstruction, and the critical step of assembling a multidisciplinary surgical team.

On this episode of SurgOnc Today, Dr. Frederick Dirbas leads a conversation with Drs. Akiko Chiba and Anna Beck, discussing the evolving landscape of endocrine therapy for hormone receptor positive breast cancer in both the adjuvant and neoadjuvant settings.